Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL
https://www.mdsabstracts.org/abstract/update-on-the-adoption-study-randomised-open-label-exploratory-trial-of-opicapone-in-parkinsons-disease/
 
J. Ferreira; W. Poewe; O. Rascol; F. Stocchi; A. Antonini; R. Costa; D. Magalhães; J. Rocha; P. Soares-da-Silva
 
Aug 31, 2023
 
Prev Next